• 11/13/2024

Bayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and was told to pay $1.56 billion in a lawsuit relating to its Roundup weedkiller.

Wall Street Journal

Bayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and was told to pay $1.56 billion in a lawsuit relating to its Roundup weedkiller.

https://www.wsj.com/health/pharma/bayer-shares-tumble-after-clinical-trial-failure-roundup-case-loss-507c1ae0